Quarterly report pursuant to Section 13 or 15(d)

LICENSE/SUPPLIER AGREEMENT (Details Narrative)

v3.24.3
LICENSE/SUPPLIER AGREEMENT (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
May 16, 2022
Oct. 31, 2020
Aug. 31, 2020
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Revenue recognized       $ 3,500,000  
License Agreement Terms [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Milestone payments $ 30,000,000.0              
Sublicense And Inventory Purchase Agreements [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Fixed consideration     $ 7,000,000.0          
Sublicense And Inventory Purchase Agreements [Member] | Event Based Milestone Payments [Member] | Maximum [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Variable consideration     26,000,000.0          
Sublicense And Inventory Purchase Agreements [Member] | Sales Based Milestone Payments [Member] | Maximum [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Variable consideration     $ 30,000,000.0          
Sublicense And Inventory Purchase Agreements [Member] | License [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Revenue recognized       0 0 0 0  
Contract assets       0   0   $ 0
Sublicense Agreement Relating to Rett Syndrome [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Fixed consideration   $ 3,000,000.0            
Sublicense Agreement Relating to Rett Syndrome [Member] | Event Based Milestone Payments [Member] | Maximum [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Variable consideration   26,500,000            
Sublicense Agreement Relating to Rett Syndrome [Member] | Sales Based Milestone Payments [Member] | Maximum [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Variable consideration   $ 30,000,000.0            
Sublicense Agreement Relating to Rett Syndrome [Member] | License [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Revenue recognized       $ 3,500,000 $ 3,500,000